Stocksigma LogoStocksigma Logo

Beta Drugs Board Approves Auditor Appointments and Director Re-appointment

Beta Drugs Ltd.'s board met on 3rd Sep'26, scheduling its AGM for 30th Sep'26 with a book closure period from 24th Sep'26 to 30th Sep'26

Beta Drugs Board Approves Auditor Appointments and Director Re-appointment

Beta Drugs Ltd 路 Outcome 路 03 Sept 2026, 11:26 pm

Beta Drugs Board Approves Auditor Appointments and Director Re-appointment Beta Drugs Ltd.'s board met on 3rd Sep'26, scheduling its AGM for 30th Sep'26 with a book closure period from 24th Sep'26 to 30th Sep'26. Crucial leadership resolutions include the re-appointment of Mr. Ashutosh Shukla as Whole-Time Director for a five-year term starting 20th Jan'27, alongside revised remuneration. Additionally, the board re-appointed Khurana Sharma and Co. as Statutory Auditors for two years (FY27-FY28) and named Charu Jindal & Co. and V.K. Srivastava & Associates as Cost and Internal Auditors, respectively, for FY27.

Original exchange filing (PDF)

More announcements from Beta Drugs Ltd

All Beta Drugs Ltd announcements